Naxalgan (Pregabalin)

Pregabalin, the active ingredient in Naxalgan, is a gabapentinoid presented as an oral tablet for oral administration. It is used to manage neuropathic pain conditions such as diabetic peripheral neuropathy and post‑herpetic neuralgia, to control partial‑onset seizures, and to treat generalized anxiety disorder in adult patients.

GNH USA supplies Naxalgan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across EU and global markets. The product conforms to EU GMP standards and is available for bulk and retail distribution.

Pregabalin is employed to treat conditions involving neuropathic pain, seizures, and anxiety.

- Diabetic peripheral neuropathic pain: reduces pain intensity and improves sensory function. - Postherpetic neuralgia: alleviates chronic burning and stabbing pain after shingles. - Fibromyalgia: lessens widespread musculoskeletal pain and fatigue. - Partial onset seizures: decreases seizure frequency in adults. - Generalized anxiety disorder: diminishes excessive worry and associated symptoms.

Pregabalin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Somnolence: increased sleepiness or fatigue. - Peripheral edema: swelling of the lower extremities. - Weight gain: gradual increase in body weight.

Serious or Rare Side Effects: - Angioedema: rapid swelling of face, lips, tongue, or throat. - Severe hypersensitivity: rash, itching, or anaphylactic reactions. - Suicidal thoughts: emergence of depressive symptoms or suicidal ideation.

Before prescribing Naxalgan, clinicians should consider several safety aspects. - Renal impairment: dose adjustment may be required in patients with reduced kidney function. - Elderly patients: monitor for increased dizziness or falls. - Concomitant CNS depressants: avoid excessive sedation when combined with alcohol or opioids. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk to the fetus or infant. - Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture and direct sunlight.

Pregabalin can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Opioids: combined use may cause profound respiratory depression and profound sedation. - CNS depressants (e.g., benzodiazepines): may result in excessive drowsiness or impaired coordination.

Moderate Interactions (Monitor Closely): - Antihypertensives: pregabalin may enhance blood‑pressure‑lowering effects. - Diuretics: monitor for increased risk of peripheral edema. - ACE inhibitors or ARBs: watch for additive effects on renal function in susceptible patients.